1. Chen, Yananlan, Xu, Xiao, Wang, Yirui, Li, Changxian, Li, Xiangcheng. 2023. Hypoxia-induced SKA3 promoted cholangiocarcinoma progression and chemoresistance by enhancing fatty acid synthesis via the regulation of PAR-dependent HIF-1a deubiquitylation. In Journal of experimental & clinical cancer research : CR, 42, 265. doi:10.1186/s13046-023-02842-7. https://pubmed.ncbi.nlm.nih.gov/37821935/
2. Wang, Chenyang, Liu, Shasha, Zhang, Xinhong, Hou, Sichuan, Qiu, Zhilei. 2022. SKA3 is a prognostic biomarker and associated with immune infiltration in bladder cancer. In Hereditas, 159, 20. doi:10.1186/s41065-022-00234-z. https://pubmed.ncbi.nlm.nih.gov/35546682/
3. Tang, Jianxin, Liu, Jing, Li, Jinjun, Zhou, Li, Jiang, Nan. 2021. Upregulation of SKA3 enhances cell proliferation and correlates with poor prognosis in hepatocellular carcinoma. In Oncology reports, 45, . doi:10.3892/or.2021.7999. https://pubmed.ncbi.nlm.nih.gov/33760206/
4. Xie, Linlin, Cheng, Shaofei, Fan, Zhengyang, Li, Qianping, Wu, Song. 2021. SKA3, negatively regulated by miR-128-3p, promotes the progression of non-small-cell lung cancer. In Personalized medicine, 19, 193-205. doi:10.2217/pme-2020-0095. https://pubmed.ncbi.nlm.nih.gov/34533066/
5. Hu, Dan-Dan, Chen, Hai-Ling, Lou, Li-Ming, Zhang, Hong, Yang, Guo-Liang. . SKA3 promotes lung adenocarcinoma metastasis through the EGFR-PI3K-Akt axis. In Bioscience reports, 40, . doi:10.1042/BSR20194335. https://pubmed.ncbi.nlm.nih.gov/32068236/
6. Zhong, Yue, Zhuang, Zhenjie, Mo, Peiju, Lu, Yuyun, Huang, Mei. 2021. Overexpression of SKA3 correlates with poor prognosis in female early breast cancer. In PeerJ, 9, e12506. doi:10.7717/peerj.12506. https://pubmed.ncbi.nlm.nih.gov/34993016/
7. Hu, Rong, Wang, Ming-Qing, Niu, Wen-Bo, Lu, Lu, Wei, Lian-Bo. 2018. SKA3 promotes cell proliferation and migration in cervical cancer by activating the PI3K/Akt signaling pathway. In Cancer cell international, 18, 183. doi:10.1186/s12935-018-0670-4. https://pubmed.ncbi.nlm.nih.gov/30459531/
智鼠故事 
